Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD
NCT ID: NCT00926861
Last Updated: 2010-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
320 participants
OBSERVATIONAL
2009-07-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy
NCT06694259
The Incidence of Complete Posterior Vitreous Degeneration After Phacoemulsification
NCT04727398
Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy.
NCT04726267
Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD
NCT00401713
Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment
NCT04158622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry AMD
male or female persons aged over 50 years with dry age-related macular degeneration
ultrasound
A-scan and B-scan ultrasound at baseline and month 6,12,24
OCT
Volume scans of spectralis OCT at baseline and month 6,12,24
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
A-scan and B-scan ultrasound at baseline and month 6,12,24
OCT
Volume scans of spectralis OCT at baseline and month 6,12,24
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 50 years
Exclusion Criteria
* Prior vitrectomy or buckle surgery
* Uveitis posterior, multifocal chorioiditis
* Pathologic myopia
* Diabetic retinopathy
* Visualization of the macula not possible (dens cataract, vitreous haemorrhage)
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanne Binder, Prof MD
Role: STUDY_CHAIR
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-052-0409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.